Michael L. Blum - 02 Mar 2022 Form 3/A - Amendment Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Commercial Officer
Signature
/s/ Paul Alloway, Attorney-in-Fact for Michael L. Blum
Issuer symbol
QTTB
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
20 Jan 2023, 15:05:30 UTC
Date Of Original Report
11 Mar 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 3,280 02 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person over-reported his Table I holdings on his original Form 3 filing and also over-reported his Table I holdings on the subsequent two Form 4s filed by the Reporting person on January 4, 2023 and January 11, 2023.